Midazolam Hydrochloride Injection, Solution
Product Images NDC 68083-108

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Midazolam Hydrochloride (NDC 68083-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 02 (Midazolam 02)

Label for Midazolam Hydrochloride Injection, USP 5 mg/mL (25 mg/5 mL), a sterile solution for intramuscular or intravenous use. The label indicates it contains benzyl alcohol as a preservative and is packaged in a 5 mL multiple-dose vial. Manufactured by Gland Pharma Limited, Hyderabad, India, with product NDC 68083-108-01.*

FDA Label Image

Image 03 (Midazolam 03)

Packaging label for Midazolam Injection, USP 25 mg/5 mL (5 mg/mL) multiple-dose vials. The label indicates intramuscular or intravenous use, sterile solution, and contains benzyl alcohol as a preservative. Manufactured by Gland Pharma Limited, the box holds 10 vials of 5 mL each. Storage instructions and lot/expiry placeholders are also included.*

FDA Label Image

Image 04 (Midazolam 04)

Midazolam Hydrochloride Injection, USP 5 mg/mL in a 10 mL multiple-dose vial. The label indicates use for intramuscular or intravenous administration and contains benzyl alcohol as a preservative. Manufactured by Gland Pharma Limited, India, the product includes formulation details and storage conditions with the NDC 68083-108-02.*

FDA Label Image

Image 05 (Midazolam 05)

Midazolam Injection, USP 50 mg/10 mL (5 mg/mL) packaging label for multiple-dose vials, manufactured by Gland Pharma Limited. The label indicates the product is for intramuscular or intravenous use, sterile, and contains benzyl alcohol as preservative. It includes storage instructions, active ingredient details, and barcode placement.*

FDA Label Image

Midazolam-01 (Midazolam 01)

Chemical structure diagram of Midazolam Hydrochloride showing the molecular arrangement, including aromatic rings and heterocyclic components, along with the associated hydrochloride (HCl) group.*

FDA Label Image

Midazolam-06 (Midazolam 06)

Chemical structure diagram showing the interconversion between Midazolam and its open-ring form. The diagram depicts two molecular structures with labels identifying Midazolam on the left and the Open-ring Form on the right, connected by a bidirectional arrow indicating reversible transformation.*

FDA Label Image

Midazolam-07 (Midazolam 07)

A line graph titled 'pH Dependence of Open-ring Form in Water' showing the percentage of open-ring form on the y-axis and pH on the x-axis. The graph illustrates a decrease in the percentage of open-ring form as pH increases from about 2.5 to 5.5, with data points connected by a line.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.